| Address: | 120 State Rte 17 #130, Paramus, NJ 07652, USA |
|---|---|
| Postal code: | 07652 |
| Phone: | (201) 857-8290 |
| Website: | http://hqspecialtypharma.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about HQ Specialty Pharma, use the form below and your opinion, advice or comment will appear in this space.
HQ Specialty Pharma is a privately held specialty pharmaceutical company headquartered in Paramus, New Jersey. A global organization, the HQ Specialty Pharma product pipeline includes a number of innovative, proprietary treatments for human health and products for animal health.
HQ Specialty Pharma - The power of creativity, fueled by ingenuity, guided by ambition, producing exciting innovations for the pharmaceutical and medical industries.
HQ Specialty Pharma is a privately held specialty pharmaceutical company. HQ Specialty Pharma product pipeline includes a number of innovative, proprietary treatments for human health and products for animal health.
(201) 857-8290. Fax: (201) 857-8291. ... More. Description: HQ Specialty Pharma is a privately held specialty pharmaceutical company headquartered in Paramus, New ...
HQ Specialty Pharma is a privately held specialty pharmaceutical company headquartered in Paramus, New Jersey. A global organization, the HQ Specialty Pharma product pipeline includes a number of innovative, proprietary treatments for human health and products for animal health.
HQ Specialty Pharma Corporation announces FDA approval of the first Levetiracetam in ... 201-857-8290 info@hqspecialtypharma.com . Title: Microsoft Word - leve.docx
About HQ Specialty Pharma HQ Specialty Pharma, headquartered in Paramus, New Jersey, is a global drug delivery and specialty pharmaceutical company developing a proprietary portfolio of innovative products for the hospital market. This press release is directed to residents of the United States.
201.857.8290 mscrofani@hqspecialtypharma.com Paramus, NJ, April 15, 2014 - HQ Specialty Pharma and its collaborating partner, WelGrace Research Group, have received tentative approval on its 505(b)(2) application for Esmolol Hydrochloride Premixed Injection, which references Brevibloc ® Injection.
For More Information, Contact: Michele Scrofani, Vice President HQ Specialty Pharma, LLC 201.857.8290 mscrofani@hqspecialtypharma.com Paramus, NJ, April 15, 2014 - HQ Specialty Pharma and its collaborating partner, WelGrace Research Group, have received tentative approval on its 505(b)(2) application for Esmolol Hydrochloride Premixed ...
206628Orig1s000 MICROBIOLOGY/VIROLOGY REVIEW(S) ... HQ Specialty Pharma Corporation Address: 120 Route 17 North ... 201-857-8290 Name of Reviewer: Jessica G. Cole ...